Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Copenhagen, 2014-10-27 16:06 CET (GLOBE NEWSWIRE) -- Nedenstående viser forventede datoer for Exiqon A/S’ afholdelse af ordinær generalforsamling samt regnskabsrapportering i...
-
Copenhagen, 2014-10-27 16:06 CET (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ Copenhagen: “EXQ”) today announced the expected dates for Exiqon A/S’ annual general meeting and financial reporting in...
-
Copenhagen, 2014-10-27 15:38 CET (GLOBE NEWSWIRE) -- Third quarter highlights include record services sales and record quarterly revenue. Exiqon A/S (NASDAQ Copenhagen: “EXQ”) today announced...
-
Tidligere fremsendt børsmeddelelse på engelsk. Nu også på dansk. Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) annoncerede i dag offentliggørelsen af data fra et populationsstudie med 554...
-
Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced the publication of data from a population based study of 554 patients with stage II colon cancer, using the company’s proprietary miRCURY...
-
Copenhagen, 2014-08-14 17:18 CEST (GLOBE NEWSWIRE) -- Exiqon A/S (NASDAQ OMX Copenhagen: “EXQ”) today announced results for the six months of 2014: In summary (DKK million) Q2...
-
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of its XploreRNA™ app for advanced cross-database searches, easy...
-
Exiqon A/S (NASDAQ OMX: EXQ), a leading supplier of high-value gene expression analysis products, today announced the launch of its miRCURY™ Exosome Isolation kits for exosome isolation from various...
-
First quarter highlights include 18% growth in North American sales, 20% increase in gross profit, positive EBIT of DKK 0.5 million and first ever reported positive Earnings Per Share of DKK...
-
Exiqon A/S (NASDAQ OMX Copenhagen), a leading supplier of high-value gene expression analysis products, today announced the launch of highly potent miRCURY LNA™ microRNA Mimics for functional...